Mucus Relief Extended Release
NDC 67296-1467, Guaifenesin, tablet, from Redpharm Drug Inc..
- Product NDC
- 67296-1467
- Status
- Listed
- Labeler
- Redpharm Drug Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA207342
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67296-1467 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUAIFENESIN600 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67296-1467-7 | 67296146707 | 1 TABLET in 1 BOTTLE (67296-1467-7) |
Linked data
RxNorm, label and prices
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 67296-1467 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67296-1467 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67296-1467. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.